ACM
GRTS

Asymmetry Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Asymmetry Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-222,817
Closed -$1.48M – 47
2020
Q2 		$1.48M Buy
+222,817
New +$1.5M 1.13% 26
2018
Q4 		– Sell
-20,000
Closed -$285K – 35
2018
Q3 		$285K Buy
+20,000
New +$285K 0.26% 35

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Asymmetry Capital Management's GRTS Position: Q3 2020 in Review

Asymmetry Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2020, closing a stake of 222,817 shares — an estimated $1.48M sold.

Asymmetry Capital Management first reported a position in GRTS in Q3 2018 and held it in 2 quarters. The position peaked at $1.48M in Q2 2020. 69 funds tracked by Wall St. Rank hold GRTS as of Q3 2020.

  • Asymmetry Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Asymmetry Capital Management sold 222,817 Gritstone bio, Inc. Common Stock shares in Q3 2020, an estimated $1.48M.
  • Asymmetry Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
  • Asymmetry Capital Management's Gritstone bio, Inc. Common Stock position peaked at $1.48M in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2020.

Based on Asymmetry Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.